PTN
Price:
$8.08
Market Cap:
$14.38M
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin...[Read more]
Industry
Biotechnology
IPO Date
1997-10-15
Stock Exchange
NASDAQ
Ticker
PTN
According to Palatin Technologies, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 73.45. This represents a change of -4668.95% compared to the average of -1.61 of the last 4 quarters.
The mean historical PE Ratio of Palatin Technologies, Inc. over the last ten years is -32.76. The current 73.45 PE Ratio has changed -22523.17% with respect to the historical average. Over the past ten years (40 quarters), PTN's PE Ratio was at its highest in in the December 2017 quarter at 537.50. The PE Ratio was at its lowest in in the March 2018 quarter at -3604.50.
Average
-32.76
Median
-57.05
Minimum
-296.96
Maximum
388.62
Discovering the peaks and valleys of Palatin Technologies, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 345.98%
Maximum Annual PE Ratio = 388.62
Minimum Annual Increase = -230.87%
Minimum Annual PE Ratio = -296.96
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.22 | -99.53% |
| 2024 | -46.04 | -3.10% |
| 2023 | -47.51 | -48.55% |
| 2022 | -92.35 | -57.01% |
| 2021 | -214.79 | -19.81% |
| 2020 | -267.86 | -184.73% |
| 2019 | 316.13 | -18.65% |
| 2018 | 388.62 | -230.87% |
| 2017 | -296.96 | 345.98% |
| 2016 | -66.59 | -78.15% |
The current PE Ratio of Palatin Technologies, Inc. (PTN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-31.26
5-year avg
-80.18
10-year avg
-32.76
Palatin Technologies, Inc.’s PE Ratio is greater than Biophytis S.A. (-0.01), greater than Eiger BioPharmaceuticals, Inc. (-0.17), greater than Notable Labs, Ltd. (-0.05), greater than Novan, Inc. (-0.11), greater than Aravive, Inc. (-0.02), greater than Fresh2 Group Limited (-0.00), greater than Affimed N.V. (-0.00), greater than Q32 Bio Inc. (5.46), greater than Midatech Pharma plc (-0.00), greater than VBI Vaccines Inc. (-0.01),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.01 | $2.61M | |
| -0.17 | $12.59M | |
| -0.05 | $2.39M | |
| -0.11 | $2.64M | |
| -0.02 | $2.95M | |
| -0.00 | $2.08M | |
| -0.00 | $2.98M | |
| 5.46 | $187.04M | |
| -0.00 | $1.98M | |
| -0.01 | $1.87M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Palatin Technologies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Palatin Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Palatin Technologies, Inc.'s PE Ratio?
How is the PE Ratio calculated for Palatin Technologies, Inc. (PTN)?
What is the highest PE Ratio for Palatin Technologies, Inc. (PTN)?
What is the 3-year average PE Ratio for Palatin Technologies, Inc. (PTN)?
What is the 5-year average PE Ratio for Palatin Technologies, Inc. (PTN)?
How does the current PE Ratio for Palatin Technologies, Inc. (PTN) compare to its historical average?